Inclusion Criteria : 
  -  Patients diagnosed with Hunter syndrome
  -  Male at the age of â‰¥ 5 
  -  Adequate abilities ( including 6 - MWT ) to participate in this study in the opinion of the investigator . 
  -  Voluntarily signed written informed consent to participation in this study
  -  Consent to contraception
Exclusion Criteria : 
  -  Prior treatment with iduronate - 2 - sulfatase ERT
  -  History of bronchotomy , bone marrow trasplanation , or cord blood transplanation . 
  -  Known hypersensitivity reactions to any of the components of the invetigational product
  -  Prior or planned administration of other investigational products within 30 days before treatment with the investigational product in this study or duirng this study . 
  -  Unable to perform 6 - MWT . 
  -  Female